An otoprotective role for the apoptosis inhibitor protein survivin

Cell Death and Disease

Volumn 1, Issue 7, 2010, Pages

  Knauer, S K ^a,b   Heinrich, U R ^a   Bier, C ^a   Habtemichael, N ^a   Docter, D ^a   Helling, K ^a   Mann, W J ^a   Stauber, R H ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Aminoglycoside antibiotics; Auditory system; Chromosomal passenger complex; Cochlea; Nitric oxide; Ototoxicity

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENTAMICIN; PROTEIN KINASE B; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUDITORY SYSTEM; CELL DAMAGE; CELL PROTECTION; CELL TYPE; COCHLEA INJURY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTI ORGAN; ENZYME PHOSPHORYLATION; EVOKED RESPONSE; GENE OVEREXPRESSION; GUINEA PIG; HEARING IMPAIRMENT; HEARING LOSS; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; NOISE INJURY; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPIRAL LIGAMENT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; COCHLEA; CYTOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CAVIA;

ANIMALS; CELLS, CULTURED; COCHLEA; FEMALE; GENTAMICINS; GUINEA PIGS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79955709963     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.25     Document Type: Article

References (34)

1. Guthrie OW. Aminoglycoside induced ototoxicity. Toxicology 2008;249:91-96.
2. Eisen MD, Ryugo DK. Hearing molecules: contributions from genetic deafness. Cell Mol Life Sci 2007;64:566-580. (Pubitemid 46712463)
3. Sha SH, Qiu JH, Schacht J. Aspirin to prevent gentamicin-induced hearing loss. N Engl J Med 2006;354:1856-1857.
4. Henderson D, Bielefeld EC, Harris KC, Hu BH. The role of oxidative stress in noise-induced hearing loss. Ear Hear 2006;27:1-19. (Pubitemid 44378662)
5. Jiang H, Sha SH, Forge A, Schacht J. Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Differ 2006;13:20-30.
6. Kalinec GM, Fernandez-Zapico ME, Urrutia R, Esteban-Cruciani N, Chen S, Kalinec F. Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss. Proc Natl Acad Sci USA 2005;102:16019-16024. (Pubitemid 41552860)
7. Cheng AG, Cunningham LL, Rubel EW. Mechanisms of hair cell death and protection. Curr Opin Otolaryngol Head Neck Surg 2005;13:343-348. (Pubitemid 41682251)
8. Atar O, Avraham KB. Therapeutics of hearing loss: expectations versus reality. Drug Discov Today 2005;10:1323-1330. (Pubitemid 41416705)
9. Le Prell CG, Yamashita D, Minami SB, Yamasoba T, Miller JM. Mechanisms of noiseinduced hearing loss indicate multiple methods of prevention. Hear Res 2007;226:22-43. (Pubitemid 46428035)
10. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47-59.
11. Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008;8:61-70.
12. Stauber RH, Mann W, Knauer SK. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 2007;67:5999-6002. (Pubitemid 47037475)
13. Kindt N, Menzebach A, Van de Wouwer M, Betz I, De Vriese A, Conway EM. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J 2008;22:510-521. (Pubitemid 351225587)
14. Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006;5:1087-1098. (Pubitemid 43881300)
15. Johnson EA, Svetlov SI, Wang KK, Hayes RL, Pineda JA. Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats. Exp Brain Res 2005;167:17-26. (Pubitemid 41578003)
16. Engels K, Knauer SK, Metzler D, Simf C, Struschka O, Bier C et al. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J Pathol 2007;211:532-540. (Pubitemid 46502429)
17. Fetz V, Bier C, Habtemichael N, Schuon R, Schweitzer A, Kunkel M et al. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int J Cancer 2009;124:2033-2041.
18. Knauer SK, Bier C, Habtemichael N, Stauber RH. The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep 2006;7:1259-1265. (Pubitemid 44835095)
19. Engels K, Knauer SK, Loibl S, Fetz V, Harter P, Schweitzer A et al. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res 2008;68:5159-5166.
20. Heinrich UR, Fischer I, Brieger J, Rumelin A, Schmidtmann I, Li H et al. Ascorbic acid reduces noise-induced nitric oxide production in the guinea pig ear. Laryngoscope 2008;118:837-842. (Pubitemid 351631277)
21. Chan DK, Lieberman DM, Musatov S, Goldfein JA, Selesnick SH, Kaplitt MG. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition. Otol Neurotol 2007;28:417-425. (Pubitemid 46607920)
22. Lechler P, Wu X, Bernhardt W, Campean V, Gastiger S, Hackenbeck T et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am J Pathol 2007;171:1483-1498. (Pubitemid 350158310)
23. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006;6:521-534. (Pubitemid 43980541)
24. Hong SH, Park SK, Cho YS, Lee HS, Kim KR, Kim MG et al. Gentamicin induced nitric oxide-related oxidative damages on vestibular afferents in the guinea pig. Hear Res 2006;211:46-53. (Pubitemid 43112410)
25. Wang J, Ladrech S, Pujol R, Brabet P, Van De Water TR, Puel JL. Caspase inhibitors, but not c-Jun. NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res 2004;64:9217-9224. (Pubitemid 39665538)
26. Wei X, Zhao L, Liu J, Dodel RC, Farlow MR, Du Y. Minocycline prevents gentamicininduced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience 2005;131:513-521. (Pubitemid 40222458)
27. Eshraghi AA, Wang J, Adil E, He J, Zine A, Bublik M et al. Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity. Hear Res 2007;226:168-177. (Pubitemid 46437290)
28. Meltser I, Tahera Y, Canlon B. Glucocorticoid receptor and mitogen-activated protein kinases activity after restraint stress and acoustic trauma. J Neurotrauma 2009;26:1835-1845.
29. Meltser I, Tahera Y, Simpson E, Hultcrantz M, Charitidi K, Gustafsson JA et al. Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest 2008;118:1563-1570. (Pubitemid 351500449)
30. Haake SM, Dinh CT, Chen S, Eshraghi AA, Van De Water TR. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hear Res 2009;255:22-32.
31. Canlon B, Henderson D, Salvi R. Pharmacological strategies for prevention and treatment of hearing loss and tinnitus. Hear Res 2007;226:1-2. (Pubitemid 46428039)
32. Knauer SK, Bier C, Schlag P, Fritzmann J, Dietmaier W, Rodel F et al. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle 2007;6:1502-1509.
33. Fetz V, Knauer SK, Bier C, Kriess JP, Stauber RH. Translocation biosensors - cellular system integrators to dissect CRM1-dependent nuclear export by chemicogenomics. Sensors 2009;7:5423-5445.
34. Selivanova O, Heinrich UR, Brieger J, Feltens R, Mann W. Fast alterations of vascular endothelial growth factor (VEGF) expression and that of its receptors (Flt-1, Flk-1 and Neuropilin) in the cochlea of guinea pigs after moderate noise exposure. Eur Arch Otorhinolaryngol 2007;264:121-128. (Pubitemid 46011292)